iRadimed IRMD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.82M-9.7% | $6.44M+15.5% | $5.58M-3.4% | $5.77M+23.2% | $4.69M-8.9% | ||
| $455K+19.5% | $380.68K-0.8% | $383.72K+84.8% | $207.6K+7.0% | $194K-0.6% | ||
| $684K-1.8% | $696.24K+4.5% | $666.08K-8.8% | $730.68K-11.5% | $826K+25.9% | ||
| $137K+106% | -$2.33M-1,627% | -$134.87K-1.3% | -$133.12K-2.4% | -$130K-222% | ||
| $40K+4,671% | -$875+98.3% | -$50.24K-181% | -$17.89K-19.3% | -$15K-316% | ||
| -$212K— | —— | $2.89M— | —— | $2.14M— | ||
| $534K— | $0-100% | $559.68K-25.5% | $751.23K+526% | $120K+106% | ||
| $362K+171% | -$513.07K-219% | $432.49K+163% | -$689.43K-199% | $694K+279% | ||
| -$1.15M-35.0% | -$853.42K-199% | $861.03K— | —— | -$1.51M-408% | ||
| -$21K-104% | $548.35K+166% | -$827.63K-190% | $917.28K+281% | -$506K-190% | ||
| $0— | —— | —— | —— | -$150K-500% | ||
| $305K+159% | $117.95K-16.8% | $141.84K-82.0% | $789.21K+44.3% | $547K+1,184% | ||
| $2.09M— | —— | —— | —— | $584K+397% | ||
| $8.29M+40.0% | $5.92M-15.2% | $6.99M-9.8% | $7.75M+80.5% | $4.29M-28.3% | ||
| $403K+37.0% | $294.17K-74.1% | $1.14M-56.8% | $2.64M-28.7% | $3.7M+32.5% | ||
| $66K— | —— | —— | —— | $220K— | ||
| -$469K-12.6% | -$416.41K+67.0% | -$1.26M+55.3% | -$2.82M+27.9% | -$3.92M-28.1% | ||
| $2.56M-70.1% | $8.55M+296% | $2.16M+0.1% | $2.16M0.0% | $2.16M+13.7% | ||
| $50K-97.8% | $2.32M+7,746% | $29.56K-69.3% | $96.29K-17.0% | $116K-78.6% | ||
| -$2.61M+76.0% | -$10.87M-396% | -$2.19M+2.9% | -$2.26M+0.9% | -$2.28M+5.8% | ||
| $5.22M+197% | -$5.37M-252% | $3.53M+32.5% | $2.66M+240% | -$1.9M-471% | ||
| $14K-99.0% | $1.42M+826% | $153.72K-93.4% | $2.34M+25,868% | $9K-99.6% | ||
| $137K+106% | -$2.33M-1,627% | -$134.87K-1.3% | -$133.12K-2.4% | -$130K-222% | ||
| -$1.15M-35.0% | -$853.42K-199% | $861.03K— | —— | -$1.51M-408% | ||
| $0— | —— | —— | —— | -$150K-500% | ||
| -$13K-153% | $24.54K+148% | $9.88K— | $0-100% | $7K-50.8% | ||
| -$21K-104% | $548.35K+166% | -$827.63K-190% | $917.28K+281% | -$506K-190% | ||
| $14K-99.0% | $1.41M+2.6% | $1.37M+765% | -$206.6K— | $0-100% | ||
| $114K+579% | $16.79K— | —— | $67.65K-28.0% | $94K— | ||
| $15K-26.2% | $20.33K+6.2% | $19.15K-57.9% | $45.52K+220% | -$38K— | ||
| $40K+4,671% | -$875+98.3% | -$50.24K-181% | -$17.89K-19.3% | -$15K-316% | ||
| $66K— | —— | —— | —— | $220K— | ||
| $305K+159% | $117.95K-16.8% | $141.84K-82.0% | $789.21K+44.3% | $547K+1,184% | ||
| $14K-99.0% | $1.42M+826% | $153.72K-93.4% | $2.34M+25,868% | $9K-99.6% | ||
| $7.89M+40.1% | $5.63M-3.8% | $5.85M+14.4% | $5.11M+759% | $595K-81.4% | ||
| $7.89M+40.1% | $5.63M-3.8% | $5.85M+14.4% | $5.11M+759% | $595K-81.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does iRadimed generate?
- iRadimed (IRMD) generated $28.9M in operating cash flow over the trailing twelve months.
- What is iRadimed's free cash flow?
- After $4.5M of capital expenditures, iRadimed's free cash flow was $24.5M over the trailing twelve months, up 67.6% year over year.
- Where does iRadimed's cash flow data come from?
- Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
